As we have described, the interactions between ETS binding, NF-κB activation, integrin αvβ3 expression, and osteopontin expression have been closely linked with more aggressive tumor biology in prior studies across cancer types, but the association with ATRX expression has not been noted previously. Here, NFKB1 is linked to neoplasm.